Medicare increases access to CGM
From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.
From April 2023 Medicare has increased access to continuous glucose monitoring (CGM) in the US to people on insulin therapies who are also having hypoglycemia.